FOGHORN THERAPEUTICS INC (FHTX) Stock Balance Sheet
NASDAQ:FHTX - Nasdaq - US3441741077 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 57.68M | 80.34M | 52.20M | 101.10M | 92.80M | |||
| Marketable Securities | 209.72M | 153.72M | 293.60M | 53.20M | 93.00M | |||
| Receivables | N/A | N/A | 0.00 | 300.00M | N/A | |||
| Other Current Assets | 3.84M | 6.12M | 5.60M | 5.30M | 4.90M | |||
| Total Current Assets | 271.23M | 240.18M | 351.40M | 459.60M | 190.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 34.58M | 42.91M | 49.40M | 56.10M | 62.30M | |||
| Other Non-Current Assets | 2.56M | 2.82M | 4.10M | 4.10M | 2.60M | |||
| Total Non-Current Assets | 37.14M | 45.73M | 53.50M | 60.20M | 64.90M | |||
| TOTAL ASSETS | 308.37M | 285.92M | 404.90M | 519.80M | 255.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 19.78M | 16.92M | 16.70M | 16.20M | 13.00M | |||
| Accounts Payable | 3.45M | 6.26M | 5.40M | 3.80M | 3.70M | |||
| Other Current Liabilities | 33.60M | 35.26M | 33.10M | 28.70M | 2.20M | |||
| Total Current Liabilities | 56.82M | 58.44M | 55.20M | 48.70M | 18.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 19.70M | |||
| Other Non-Current Liabilities | 279.83M | 304.67M | 349.60M | 374.20M | 70.90M | |||
| Total Non-Current Liabilities | 279.83M | 304.67M | 349.60M | 374.20M | 90.60M | |||
| TOTAL LIABILITIES | 336.66M | 363.11M | 404.80M | 422.90M | 109.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -538.68M | -471.56M | -373.10M | -264.30M | -162.90M | |||
| Additional Paid In Capital | 510.03M | 395.20M | 377.20M | 361.10M | 309.10M | |||
| Common Shares | 6.00K | 4.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 360.00K | -826.00K | -4.00M | 0.00 | 0.00 | |||
| Shares Outstanding | 55.59M | 42.28M | 41.80M | 41.30M | 36.80M | |||
| Tangible Book Value per Share | -0.51 | -1.83 | 0.00 | 2.35 | 3.97 | |||
| Total Shareholders' Equity | -28.29M | -77.19M | 100.00K | 96.90M | 146.20M | |||
| TOTAL LIABILITIES AND EQUITY | 308.37M | 285.92M | 404.90M | 519.80M | 255.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.13 | |||
| Current Ratio | 4.77 | 4.11 | 6.37 | 9.44 | 10.14 | |||
| Return On Assets (ROA) | -29.58% | -34.42% | -26.89% | -19.49% | -26.92% | |||
| Return On Equity (ROE) | N/A | N/A | -108880.00% | -104.56% | -47.06% | |||
All data in USD , ROIC based on taxRate of 0.21